These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31266140)

  • 61. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Robinson JG
    J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A qualitative study to identify barriers and facilitators to implementation of pilot interventions in the Veterans Health Administration (VHA) Northwest Network.
    Sharp ND; Pineros SL; Hsu C; Starks H; Sales AE
    Worldviews Evid Based Nurs; 2004; 1(2):129-39. PubMed ID: 17129326
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Understanding the dissemination of appointment-based synchronization models using the CFIR framework.
    Patterson J; Holdford D
    Res Social Adm Pharm; 2017; 13(5):914-921. PubMed ID: 28595895
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Barriers, facilitators, and recommendations related to implementing the Baby-Friendly Initiative (BFI): an integrative review.
    Semenic S; Childerhose JE; Lauzière J; Groleau D
    J Hum Lact; 2012 Aug; 28(3):317-34. PubMed ID: 22628290
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.
    Alonso R; Perez de Isla L; Muñiz-Grijalvo O; Mata P
    Vasc Health Risk Manag; 2020; 16():11-25. PubMed ID: 32021224
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Deploying Clinical Decision Support for Familial Hypercholesterolemia.
    Bangash H; Sutton J; Gundelach JH; Pencille L; Makkawy A; Elsekaily O; Dikilitas O; Mir A; Freimuth R; Caraballo PJ; Kullo IJ
    ACI open; 2020 Jul; 4(2):e157-e161. PubMed ID: 36644330
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Implementation of internet-delivered cognitive behavior therapy within community mental health clinics: a process evaluation using the consolidated framework for implementation research.
    Hadjistavropoulos HD; Nugent MM; Dirkse D; Pugh N
    BMC Psychiatry; 2017 Sep; 17(1):331. PubMed ID: 28899365
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Integrating Patient-Reported Outcomes Into Clinical Genetic Testing for Familial Hypercholesterolemia.
    Hendricks-Sturrup RM; Block R; Lu CY
    J Patient Cent Res Rev; 2021; 8(4):336-339. PubMed ID: 34722802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care.
    Rodriguez NJ; Ricker C; Stoffel EM; Syngal S
    Gastroenterology; 2023 Jan; 164(1):5-8. PubMed ID: 36529467
    [No Abstract]   [Full Text] [Related]  

  • 71. Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care.
    Rodriguez NJ; Ricker C; Stoffel EM; Syngal S
    Clin Gastroenterol Hepatol; 2023 Jan; 21(1):3-7. PubMed ID: 36549838
    [No Abstract]   [Full Text] [Related]  

  • 72. Real-world utilization of guideline-directed genetic testing in inherited cardiovascular diseases.
    Longoni M; Bhasin K; Ward A; Lee D; Nisson M; Bhatt S; Rodriguez F; Dash R
    Front Cardiovasc Med; 2023; 10():1272433. PubMed ID: 37915745
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Addressing the underdiagnosis of familial hypercholesterolemia: A mixed methods study exploring the knowledge and practice behaviors of cardiology healthcare providers.
    Kalia I; Shope R; Reilly M; Schwartz L
    J Clin Transl Sci; 2023; 7(1):e92. PubMed ID: 37125063
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.
    Tricou EP; Morgan KM; Betts M; Sturm AC
    Curr Atheroscler Rep; 2023 May; 25(5):197-208. PubMed ID: 37060538
    [TBL] [Abstract][Full Text] [Related]  

  • 75. How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?
    Sarkies M; Jones LK; Pang J; Sullivan D; Watts GF
    Curr Atheroscler Rep; 2023 Apr; 25(4):133-143. PubMed ID: 36806760
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.
    Schmidlen TJ; Bristow SL; Hatchell KE; Esplin ED; Nussbaum RL; Haverfield EV
    Front Genet; 2022; 13():867226. PubMed ID: 35783293
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient experiences align with the familial hypercholesterolemia global call to action.
    Jones LK; Walters N; Brangan A; Ahmed CD; Wilemon KA; Campbell-Salome G; Rahm AK; Gidding SS; Sturm AC
    Am J Prev Cardiol; 2022 Jun; 10():100344. PubMed ID: 35517872
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication.
    Campbell-Salome G; Walters NL; Ladd IG; Sheldon A; Ahmed CD; Brangan A; McMinn MN; Rahm AK; Schwartz MLB; Tricou E; Fisher CL; Sturm AC
    Transl Behav Med; 2022 Jul; 12(7):800-809. PubMed ID: 35429393
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.